SEC Filings

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
8-K 8-K 11/20/2017 11/14/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
8-K 8-K 11/13/2017 11/13/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 11/13/2017 9/30/2017
8-K 8-K 11/2/2017 11/1/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holder; and Financial Statements and Exhibits.
Proxy DEF 14A 9/18/2017 11/1/2017
Proxy PRE 14A 9/8/2017 11/1/2017
8-K 8-K 8/14/2017 8/14/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 8/14/2017 6/30/2017
8-K 8-K 7/6/2017 6/29/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 6/16/2017 6/15/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Submission of Matters to a Vote of Security Holder.
Prospectus 424B3 6/1/2017
Registration Statement S-3/A 5/30/2017
8-K 8-K 5/26/2017 5/23/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
8-K 8-K 5/22/2017 5/22/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Regulation FD Disclosure and Financial Statements and Exhibits.
Registration Statement S-8 5/17/2017
Registration Statement S-3 5/17/2017
8-K 8-K 5/15/2017 5/15/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 5/15/2017 5/15/2017
Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 5/15/2017 3/31/2017
Proxy DEF 14A 5/12/2017 6/15/2017

Displaying 1 to 20 (of 151 filings)